(Q38354364)

2 September 2017

title

Description of the chemical and pharmacological characteristics of a new hemisynthetic ultra-low-molecular-weight heparin, AVE5026. (English)

1 reference

2 September 2017

1 reference

C Viskov

1

1 reference

2 September 2017

M Just

2

1 reference

2 September 2017

V Laux

3

1 reference

2 September 2017

P Mourier

4

1 reference

2 September 2017

M Lorenz

5

1 reference

2 September 2017

publication date

27 April 2009

1 reference

Journal of Thrombosis and Haemostasis

2 September 2017

published in

1 reference

2 September 2017

volume

7

1 reference

2 September 2017

issue

7

1 reference

2 September 2017

page(s)

1143-1151

1 reference

The molecular-weight dependence of the rate-enhancing effect of heparin on the inhibition of thrombin, factor Xa, factor IXa, factor XIa, factor XIIa and kallikrein by antithrombin

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03447.X

Crossref

reference URL

Biochemical and pharmacological properties of SANORG 32701. Comparison with the "synthetic pentasaccharide' (SR 90107/ORG 31540) and standard heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2009.03447.X

Crossref

reference URL

10.1111/J.1538-7836.2009.03447.X

21 January 2018

Identifiers

DOI

1 reference

2 September 2017

1 reference